Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pediatrics/Neonatology | Cardiology/Vascular Diseases | Family Medicine
 Disease Category: High Blood Pressure (Hypertension - Pediatric)
Location: United States, UT

Trial Information

Hypertension

A Phase I Randomized, Placebo-Controlled, Double-Blind Study in Hypertensive Patients of the Blood Pressure Interaction between TC-5214 and Anti-Hypertensive Medications (Calcium Channel Blockers, Beta Blockers, and ACE Inhibitors)

Patient Inclusion Criteria:

  • Males or Female patients with chronic, stable hypertension treated for at least 1 month with a calcium channel blocker, a beta blocker, or an ACE inhibitor.
  • Ages 18 to 65
  • BMI 19-35 kg/m2

Patient Exclusion Criteria:

  • History or presence of gastrointestinal, hepatic, or renal disease
  • History of seizure activity
  • Hepatitis B, C or HIV

Cher Struck, Director Marketing and Recruiting
Lifetree Clinical Research
3838 South 700 East Suite 202
Salt Lake CIty, UT 84106
Phone: 801-269-8200
Email: chers@lifetreeresearch.com

View Map

Research Center Information: Lifetree Clinical Research

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.